These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25344840)

  • 1. Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity.
    Sarvagalla S; Singh VK; Ke YY; Shiao HY; Lin WH; Hsieh HP; Hsu JT; Coumar MS
    J Comput Aided Mol Des; 2015 Jan; 29(1):89-100. PubMed ID: 25344840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand efficiency based approach for efficient virtual screening of compound libraries.
    Ke YY; Coumar MS; Shiao HY; Wang WC; Chen CW; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Chang CM; Hsieh HP
    Eur J Med Chem; 2014 Aug; 83():226-35. PubMed ID: 24960626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening.
    Kong Y; Bender A; Yan A
    J Chem Inf Model; 2018 Jan; 58(1):36-47. PubMed ID: 29202231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design.
    Chang CF; Lin WH; Ke YY; Lin YS; Wang WC; Chen CH; Kuo PC; Hsu JTA; Uang BJ; Hsieh HP
    Eur J Med Chem; 2016 Nov; 124():186-199. PubMed ID: 27573544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA).
    Hijjawi MS; Abutayeh RF; Taha MO
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33353031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitor.
    Shiao HY; Coumar MS; Chang CW; Ke YY; Chi YH; Chu CY; Sun HY; Chen CH; Lin WH; Fung KS; Kuo PC; Huang CT; Chang KY; Lu CT; Hsu JT; Chen CT; Jiaang WT; Chao YS; Hsieh HP
    J Med Chem; 2013 Jul; 56(13):5247-60. PubMed ID: 23808327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.
    Kilchmann F; Marcaida MJ; Kotak S; Schick T; Boss SD; Awale M; Gönczy P; Reymond JL
    J Med Chem; 2016 Aug; 59(15):7188-211. PubMed ID: 27391133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors.
    Zheng Y; Zheng M; Ling X; Liu Y; Xue Y; An L; Gu N; Ji M
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3523-30. PubMed ID: 23664099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery of aurora kinase inhibitor by multi-docking-based virtual screening.
    Kim JT; Jung SH; Kang SY; Ryu CK; Kang NS
    Int J Mol Sci; 2014 Nov; 15(11):20403-12. PubMed ID: 25383681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel 2,4-disubstituted pyrimidines as Aurora kinase inhibitors.
    Xu Y; Hao SY; Zhang XJ; Li WB; Qiao XP; Wang ZX; Chen SW
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126885. PubMed ID: 31862411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening and discovery of novel aurora kinase inhibitors.
    Raghu R; Devaraji V; Leena K; Riyaz SD; Rani PB; Kumar BS; Naik PK; Dubey PK; Velmurugan D; Vijayalakshmi M
    Curr Top Med Chem; 2014; 14(17):2006-19. PubMed ID: 25262798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification.
    Ke YY; Singh VK; Coumar MS; Hsu YC; Wang WC; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Shih C; Hsieh HP
    Sci Rep; 2015 Jun; 5():11702. PubMed ID: 26118648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new novel scaffold for Aurora A inhibition by pharmacophore modeling and virtual screening.
    Chavan SR; Dash RC; Alam MS; Hirwani RR
    Mol Divers; 2014 Nov; 18(4):853-63. PubMed ID: 25112687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 3,5,6-substituted indolin-2-one's inhibitors of Aurora B by development of a luminescent kinase assay.
    Zhang L; Yang T; Xie X; Liu G
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2937-42. PubMed ID: 26048792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, SAR studies, and X-ray co-crystallographic analysis of a novel furanopyrimidine aurora kinase A inhibitor.
    Coumar MS; Tsai MT; Chu CY; Uang BJ; Lin WH; Chang CY; Chang TY; Leou JS; Teng CH; Wu JS; Fang MY; Chen CH; Hsu JT; Wu SY; Chao YS; Hsieh HP
    ChemMedChem; 2010 Feb; 5(2):255-67. PubMed ID: 20039358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General Ser/Thr Kinases Pharmacophore Approach for Selective Kinase Inhibitors Search as Exemplified by Design of Potent and Selective Aurora A Inhibitors.
    Vasilevich NI; Aksenova EA; Kazyulkin DN; Afanasyev II
    Chem Biol Drug Des; 2016 Jul; 88(1):54-65. PubMed ID: 26825399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells.
    Bavetsias V; Faisal A; Crumpler S; Brown N; Kosmopoulou M; Joshi A; Atrash B; Pérez-Fuertes Y; Schmitt JA; Boxall KJ; Burke R; Sun C; Avery S; Bush K; Henley A; Raynaud FI; Workman P; Bayliss R; Linardopoulos S; Blagg J
    J Med Chem; 2013 Nov; 56(22):9122-35. PubMed ID: 24195668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a Pyrazolo[4,3-d]pyrimidine Inhibitor of Cyclin-Dependent Kinases 2 and 5 and Aurora A With Pro-Apoptotic and Anti-Angiogenic Activity In Vitro.
    Řezníčková E; Weitensteiner S; Havlíček L; Jorda R; Gucký T; Berka K; Bazgier V; Zahler S; Kryštof V; Strnad M
    Chem Biol Drug Des; 2015 Dec; 86(6):1528-40. PubMed ID: 26198005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent Aurora kinase inhibitors.
    Song D; Park Y; Yoon J; Aman W; Hah JM; Ryu JS
    Bioorg Med Chem; 2014 Sep; 22(17):4855-66. PubMed ID: 25042560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Aurora-A Inhibitors by Ligand and Structure-Based Virtual Screening.
    Morshed MN
    Mol Inform; 2014 May; 33(5):369-81. PubMed ID: 27485892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.